Beta Bionics (BBNX) Accumulated Expenses (2023 - 2026)

Beta Bionics has disclosed Accumulated Expenses across 4 years of filings, most recently posting $17.3 million for Q1 2026.

• Accumulated Expenses for Q1 2026 came in at $17.3 million, up 64.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $17.3 million (up 64.02% YoY), and the FY2025 annual result was $22.4 million, up 41.72% from the prior year.
• Accumulated Expenses came in at $17.3 million for Q1 2026 at Beta Bionics, down from $22.4 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $22.4 million in Q4 2025 to a low of $8.1 million in Q4 2023.
• The 4-year median for Accumulated Expenses is $15.8 million (2024), against an average of $15.0 million.
• Across the five-year window, Accumulated Expenses surged 94.73% in 2024 and surged 41.72% in 2025, its largest moves.
• Beta Bionics' Accumulated Expenses stood at $8.1 million in 2023, then soared by 94.73% to $15.8 million in 2024, then surged by 41.72% to $22.4 million in 2025, then dropped by 22.75% to $17.3 million in 2026.
• The last three Accumulated Expenses figures came in at $17.3 million (Q1 2026), $22.4 million (Q4 2025), and $17.6 million (Q3 2025), per Business Quant data.